Literature DB >> 15994831

RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.

Daniel J J Carr1, Lisa Tomanek, Robert H Silverman, Iain L Campbell, Bryan R G Williams.   

Abstract

We investigated the mechanism of resistance to genital herpes simplex virus type 2 (HSV-2) infection in mice transfected with the murine alpha-1 interferon (IFN-alpha1) transgene. In situ transfection of mice with the IFN-alpha1 transgene resulted in an elevation in an IFN-responsive gene, RNA-dependent protein kinase (PKR), but not 2',5'-oligoadenylate synthetases (OAS), in vaginal tissue. Coupled with the finding that mice lacking a functional PKR pathway were no longer resistant to genital HSV-2 infection following transfection with the IFN-alpha1 transgene in comparison to wild-type mice or mice lacking a functional OAS pathway, these results suggest that PKR is the dominant antiviral pathway activated by the IFN-alpha1 transgene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994831      PMCID: PMC1168756          DOI: 10.1128/JVI.79.14.9341-9345.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

2.  Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.

Authors:  S Noisakran; I L Campbell; D J Carr
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

3.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

Authors:  A Zhou; J M Paranjape; S D Der; B R Williams; R H Silverman
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

4.  The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.

Authors:  M B Parr; E L Parr
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

5.  Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2.

Authors:  M B Parr; E L Parr
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

6.  Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.

Authors:  G N Milligan
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.

Authors:  G N Milligan; D I Bernstein
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

8.  Unexpected correlation in the sensitivity of 19 herpes simplex virus strains to types I and II interferons.

Authors:  Y Arao; Y Ando; M Narita; T Kurata
Journal:  J Interferon Cytokine Res       Date:  1997-09       Impact factor: 2.607

9.  Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

Authors:  M B Parr; E L Parr
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.

Authors:  Y Akwa; D E Hassett; M L Eloranta; K Sandberg; E Masliah; H Powell; J L Whitton; F E Bloom; I L Campbell
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

View more
  9 in total

1.  Homeostatic interferon expression in neurons is sufficient for early control of viral infection.

Authors:  Sarah E Cavanaugh; Alicia M Holmgren; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2014-12-16       Impact factor: 3.478

2.  The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.

Authors:  Daniel J J Carr; Todd Wuest; Lisa Tomanek; Robert H Silverman; Bryan R G Williams
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

3.  Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Authors:  Christopher D Conrady; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

4.  Innate and adaptive immune responses to herpes simplex virus.

Authors:  Tracy Chew; Kathryne E Taylor; Karen L Mossman
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

5.  Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality.

Authors:  Bobbie Ann Austin; Cassandra M James; Peter Härle; Daniel J J Carr
Journal:  Biol Proced Online       Date:  2006-06-14       Impact factor: 3.244

Review 6.  Herpes Simplex Virus Evasion of Early Host Antiviral Responses.

Authors:  Eduardo I Tognarelli; Tomás F Palomino; Nicolás Corrales; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

Review 7.  Intrinsic cellular defenses against virus infection by antiviral type I interferon.

Authors:  Kyung-Hyun Boo; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

Review 8.  Evasion of early antiviral responses by herpes simplex viruses.

Authors:  Paula A Suazo; Francisco J Ibañez; Angello R Retamal-Díaz; Marysol V Paz-Fiblas; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Mediators Inflamm       Date:  2015-03-30       Impact factor: 4.711

Review 9.  HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.

Authors:  Xiao-Peng Zhu; Zaka S Muhammad; Jian-Guang Wang; Wu Lin; Shi-Kun Guo; Wei Zhang
Journal:  Viruses       Date:  2014-01-24       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.